M&A Deal Summary |
|
---|---|
Date | 2021-07-21 |
Target | lifebrain |
Sector | Healthcare Services |
Buyer(s) | Cerba HealthCare |
Sellers(s) | Investindustrial |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1967 |
Sector | Healthcare Services |
Employees | 4,300 |
Revenue | 630M EUR (2016) |
Cerba HealthCare is an operator of clinical pathology laboratories, with a number one position in France and strong market positions in Belgium and Luxembourg. The majority of Cerba's revenues are generated via routine lab tests. Cerba HealthCare was founded in 1967 and is based in Issy-les-Moulineaux, France.
DEAL STATS | # |
---|---|
Overall | 4 of 5 |
Sector (Healthcare Services) | 1 of 1 |
Type (Add-on Acquisition) | 4 of 5 |
Country (Austria) | 1 of 1 |
Year (2021) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2018-10-01 |
Accolab Laboratories
Issy-les-Moulineaux, France Accolab Laboratories is a group of eight clinical laboratories located in the area of Bordeaux, Lyon and in Spain. Accolab offers a comprehensive medical diagnostics offering, combining medical biology and anatomocytopathology. Accolab Laboratories was founded in 2010 and is based in Issy-les-Moulineaux, France. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-12-16 |
ViroClinics
Rotterdam, Netherlands ViroClinics is a virology contract research organization, serving the biopharmaceutical community with a broad range of preclinical, clinical diagnostic, assay development and clinical trial logistics services. Operating at a global level, Viroclinics is the preferred virology testing laboratory for several of the top-10 biopharmaceutical companies. Viroclinics’ extensive experience with clinical and preclinical studies for viruses, including its specialty in respiratory viruses, puts the company at the forefront in supporting the development of vaccines, antibodies and antiviral compounds targeting viral infectious diseases. ViroClinics was founded in 2001 and is based in Rotterdam, Netherlands. |
Buy | - |
Category | Private Equity Firm |
---|---|
Founded | 1990 |
PE ASSETS | 11.0B EUR |
Size | Mega |
Type | Sector Agnostic |
Investindustrial is an investment firm focused on creating global leaders through organic growth and acquisitions. The Firm is operationally driven and seeks opportunities in Southern Europe. Areas of interest include services, consumer, retail, leisure, and industrial manufacturing. Investindustrial has offices in London, Luxembourg, Milan, Lugano, Barcelona, Shanghai, and New York.
DEAL STATS | # |
---|---|
Overall | 31 of 34 |
Sector (Healthcare Services) | 3 of 3 |
Type (Add-on Acquisition) | 15 of 16 |
Country (Austria) | 1 of 1 |
Year (2021) | 3 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-07-01 |
Guala Closures
Alessandria, Italy Guala Closures is a manufacturer of spirits and wine closures through operating in 5 continents with 27 production sites and has a commercial presence in over 100 countries; about 90% of the group's turnover is generated outside of Italy. Guala Closures was founded in 1954 and is based in Alessandria, Italy. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-10-01 |
Rimac Automobili
Sveta Nedelja, Croatia Rimac Automobili designs, develops and manufactures the Nevera an, all-electric hypercar, the fastest accelerating car in the world (quarter-mile in 8.9 seconds, 0-100 km/h in 1.97 seconds), with over 1,900 horsepower and a top speed of more than 400 km/h. Rimac has completed a combination of its hypercar business with Bugatti, the high-performance brand belonging to the Volkswagen group. Rimac Automobili was founded in 2009 and is based in Sveta Nedelja, Croatia. |
Buy | - |